Sander Markx
Co-Director · New York Presbyterian Hospital
Credentials: ·
History
- 2009–2010
- 2001–2005
Doctor of Medicine
Research
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Annals of Neurology · 2011 · 335 citations
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy
Molecular Psychiatry · 2008 · 235 citations
Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission
Nature · 2014 · 153 citations
- BX
11 papers · 2 as a resident
10 papers
4 papers
2 papers
2 papers
2 papers
2 papers
- JF
2 papers
Grants
- 2024–2029
1/5 Clinical Outcome Prediction of Psychosis from EHRs (COPPER)
National Institute of Mental Health · R01
PI · $1M · Columbia University Health Sciences
Clinical trials
- 2016–2017
PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations
Principal investigator · Terminated
Jeffrey A. Lieberman, MD